Production (Stage)
Atai Life Sciences N.V.
ATAI
$2.32
$0.010.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.06% | -112.98% | -159.41% | -73.45% | 19.38% |
| Total Depreciation and Amortization | 160.24% | 122.77% | 12.16% | 3.80% | 27.69% |
| Total Amortization of Deferred Charges | 52.04% | 89.90% | 32.32% | 7.69% | 19.51% |
| Total Other Non-Cash Items | 10.93% | 381.01% | 115.45% | 303.31% | 9.20% |
| Change in Net Operating Assets | 65.52% | -253.01% | -988.86% | 246.57% | -236.99% |
| Cash from Operations | 20.96% | -10.62% | -4.94% | 28.24% | -6.93% |
| Capital Expenditure | -- | 25.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -25.21% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -187.14% | 828.52% | 153.99% | 173.98% | -29.62% |
| Cash from Investing | -196.02% | 897.08% | 153.44% | 174.08% | -28.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 710.53% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -- | 101.82% | -- | 426.00% | -- |
| Foreign Exchange rate Adjustments | 150.00% | 158.02% | -25.47% | 186.84% | -140.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 375.65% | 44.50% | 116.46% | 101.04% | -136.19% |